Home>
US Stocks>
Akebia Therapeutics Inc

Akebia Therapeutics Inc share price today

(AKBA)

Akebia Therapeutics Inc share price is $2.04 & ₹172.75 as on 10 Dec 2024, 2.30 'hrs' IST

$2.04

▲

-0.01

(-0.49%)

Market is closed - opens 8 PM, 10 Dec 2024

View live Akebia Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Akebia Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Akebia Therapeutics Inc. Get details on the Indian mutual funds that are investing in Akebia Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Akebia Therapeutics Inc's financials.

Akebia Therapeutics Inc share price movements

$2.04
$2.08
$2.04
0.25%
Downside
Day's Volatility :2.16%
Upside
1.92%
$0.80
$2.48
$2.04
60.78%
Downside
52 Weeks Volatility :67.74%
Upside
17.74%

Akebia Therapeutics Inc Returns

Period	Akebia Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	36.49%	-6.4%	0.0%
6 Months	81.98%	-0.9%	0.0%
1 Year	81.98%	9.9%	0.0%
3 Years	-20.78%	8.2%	-20.3%

Akebia Therapeutics Inc Key Statistics

in dollars & INR

Previous Close	$2.05
Open	$2.05
Today's High	$2.08
Today's Low	$2.035
Market Capitalization	$442.9M
Today's Volume	$1.2M
52 Week High	$2.48
52 Week Low	$0.8
Revenue TTM	$169.9M
EBITDA	$4.4M
Earnings Per Share (EPS)	$-0.22
Profit Margin	-27.07%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-553.45%

How to invest in Akebia Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Akebia Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Akebia Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Akebia Therapeutics Inc or AKBA on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Akebia Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Akebia Therapeutics Inc shares which would translate to 0.415 fractional shares of Akebia Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Akebia Therapeutics Inc

96%

Period: Sep 10, 2024 to Dec 9, 2024. Change in 30 Days versus previous period

Search volume for Akebia Therapeutics Inc on INDmoney from India has grown in the last 30 days as on Dec 10, 2024. 96% more investors are searching Akebia Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Akebia Therapeutics Inc

BlackRock Inc
5.33%
Vanguard Group Inc
4.62%
SATTER MANAGEMENT CO., L.P.
2.63%
Geode Capital Management, LLC
2.18%
Renaissance Technologies Corp
1.70%
State Street Corp
1.57%

Analyst Recommendation on Akebia Therapeutics Inc

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Akebia Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Akebia Therapeutics Inc

What analysts predicted

Upside of 169.61%

Current:

$2.04

Target:

$5.50

Insights on Akebia Therapeutics Inc

Price Movement
In the last 6 months, AKBA stock has moved up by 90.6%
Decreasing Revenue
Revenue is down for the last 2 quarters, 43.64M → 37.42M (in $), with an average decrease of 14.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -8.58M → -20.03M (in $), with an average decrease of 133.5% per quarter

Akebia Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Akebia Therapeutics Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Akebia Therapeutics Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Akebia Therapeutics Inc	1.51%	81.98%	81.98%	-20.78%	-68.19%
Neurocrine Biosciences Inc.	-0.59%	-5.05%	6.67%	53.4%	13.45%
Haleon Plc Spon Ads	2.31%	16.95%	18.37%	31.31%	31.31%
Zoetis Inc.	-0.78%	-2.11%	-7.75%	-24.78%	40.57%
Viatris Inc.	-1.53%	21.15%	31.13%	2.71%	-21.11%
Catalent, Inc.	4.47%	11.31%	63.78%	-50.26%	18.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Akebia Therapeutics Inc	NA	NA	0.0	-0.26	-5.53	-0.09	NA	-0.24
Neurocrine Biosciences Inc.	33.98	33.98	0.3	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	29.36	29.36	1.74	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	32.98	32.98	2.44	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.67	-0.04	0.02	0.04	16.58
Catalent, Inc.	211.02	NA	514.17	0.2	-0.11	0.0	NA	19.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Akebia Therapeutics Inc	Buy	$442.9M	-68.19%	NA	-27.07%
Neurocrine Biosciences Inc.	Buy	$12.9B	13.45%	33.98	17.21%
Haleon Plc Spon Ads	Buy	$43.8B	31.31%	29.36	10.75%
Zoetis Inc.	Buy	$79.1B	40.57%	32.98	26.55%
Viatris Inc.	Hold	$15.1B	-21.11%	224.4	-5.87%
Catalent, Inc.	Hold	$11.2B	18.91%	211.02	-9.34%

About Akebia Therapeutics Inc

akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients. akebia’s global phase 3 program for vadadustat, which includes the pro2tect studies for non-dialysis patients with anemia associated with chronic kidney disease and the inno2vate studies for dialysis-dependent patients, is currently ongoing. for more information, please visit our website at www.akebia.com.

Organization	Akebia Therapeutics Inc
Employees	167
CEO	Mr. John P. Butler MBA
Industry	Health Technology

Management People of Akebia Therapeutics Inc

Name	Title
Mr. John P. Butler MBA	CEO, President & Director
Dr. Steven Keith Burke M.D.	Senior VP of Research & Development and Chief Medical Officer
Mr. Erik John Ostrowski M.B.A.	Senior VP, CFO & Chief Business Officer
Mr. Richard C. Malabre	Chief Accounting Officer
Ms. Kimberly Garko	Senior VP & Chief Technical Officer
Ms. Tracey Vetterick	Vice President of Portfolio Strategy & Corporate Administration
Mercedes Carrasco	Senior Director of Investor & Corporate Communications
Ms. Carolyn Rucci	Senior VP of Legal, General Counsel & Secretary
Ms. Meredith Bowman	Senior VP & Chief People Officer
Mr. Nicholas Grund	Senior VP & Chief Commercial Officer

Important FAQs about investing in Akebia Therapeutics Inc from India :

What is Akebia Therapeutics Inc share price today?

Akebia Therapeutics Inc (AKBA) share price today is $2.04.

Can Indians buy Akebia Therapeutics Inc shares?

Yes, Indians can invest in the Akebia Therapeutics Inc (AKBA) from India.

With INDmoney, you can buy Akebia Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Akebia Therapeutics Inc at zero transaction cost.

How can I buy Akebia Therapeutics Inc shares from India?

It is very easy to buy Akebia Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Akebia Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Akebia Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Akebia Therapeutics Inc stocks?

To start investing in Akebia Therapeutics Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.